Harbin Pharmaceutical (600664)
Overview
Harbin Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally. The company offers pharmaceutical products for respiratory, chronic, digestive, blood and hematopoietic, anti-tumor and immunomodulatory, anti-inflammatory and analgesic, anti-virus and anti-infection, cerebrovascular, and cardiovascular diseases, as well as mineral and nutritional supplements, Chinese med
Employees10039
Market Cap$8.0B
Revenue$16.0B
Listed OnShanghai Stock Exchange
Ticker600664
CEOMr. Chuanyou Lu
HeadquartersHarbin